IBDEI09V ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4199,2)
 ;;=^295695
 ;;^UTILITY(U,$J,358.3,4200,0)
 ;;=V82.2^^17^196^53
 ;;^UTILITY(U,$J,358.3,4200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4200,1,3,0)
 ;;=3^SCREEN-RHEUMAT DIS NEC
 ;;^UTILITY(U,$J,358.3,4200,1,4,0)
 ;;=4^V82.2
 ;;^UTILITY(U,$J,358.3,4200,2)
 ;;=^295696
 ;;^UTILITY(U,$J,358.3,4201,0)
 ;;=V82.3^^17^196^13
 ;;^UTILITY(U,$J,358.3,4201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4201,1,3,0)
 ;;=3^SCREEN-CONG HIP DISLOCAT
 ;;^UTILITY(U,$J,358.3,4201,1,4,0)
 ;;=4^V82.3
 ;;^UTILITY(U,$J,358.3,4201,2)
 ;;=^295697
 ;;^UTILITY(U,$J,358.3,4202,0)
 ;;=V82.4^^17^196^50
 ;;^UTILITY(U,$J,358.3,4202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4202,1,3,0)
 ;;=3^SCREEN-POSTNAT,CHROM ANOM
 ;;^UTILITY(U,$J,358.3,4202,1,4,0)
 ;;=4^V82.4
 ;;^UTILITY(U,$J,358.3,4202,2)
 ;;=^295698
 ;;^UTILITY(U,$J,358.3,4203,0)
 ;;=V82.5^^17^196^14
 ;;^UTILITY(U,$J,358.3,4203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4203,1,3,0)
 ;;=3^SCREEN-CONTAMINATION NEC
 ;;^UTILITY(U,$J,358.3,4203,1,4,0)
 ;;=4^V82.5
 ;;^UTILITY(U,$J,358.3,4203,2)
 ;;=^321508
 ;;^UTILITY(U,$J,358.3,4204,0)
 ;;=V82.6^^17^196^42
 ;;^UTILITY(U,$J,358.3,4204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4204,1,3,0)
 ;;=3^SCREEN-MULTIPHASIC
 ;;^UTILITY(U,$J,358.3,4204,1,4,0)
 ;;=4^V82.6
 ;;^UTILITY(U,$J,358.3,4204,2)
 ;;=^79695
 ;;^UTILITY(U,$J,358.3,4205,0)
 ;;=V82.71^^17^196^25
 ;;^UTILITY(U,$J,358.3,4205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4205,1,3,0)
 ;;=3^SCREEN-GENTC DIS CARRIER
 ;;^UTILITY(U,$J,358.3,4205,1,4,0)
 ;;=4^V82.71
 ;;^UTILITY(U,$J,358.3,4205,2)
 ;;=^334220
 ;;^UTILITY(U,$J,358.3,4206,0)
 ;;=V82.79^^17^196^24
 ;;^UTILITY(U,$J,358.3,4206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4206,1,3,0)
 ;;=3^SCREEN-GENETIC
 ;;^UTILITY(U,$J,358.3,4206,1,4,0)
 ;;=4^V82.79
 ;;^UTILITY(U,$J,358.3,4206,2)
 ;;=^334221
 ;;^UTILITY(U,$J,358.3,4207,0)
 ;;=V82.81^^17^196^47
 ;;^UTILITY(U,$J,358.3,4207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4207,1,3,0)
 ;;=3^SCREEN-OSTEOPOROSIS
 ;;^UTILITY(U,$J,358.3,4207,1,4,0)
 ;;=4^V82.81
 ;;^UTILITY(U,$J,358.3,4207,2)
 ;;=^322098
 ;;^UTILITY(U,$J,358.3,4208,0)
 ;;=V82.9^^17^196^12
 ;;^UTILITY(U,$J,358.3,4208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4208,1,3,0)
 ;;=3^SCREEN-CONDITION NOS
 ;;^UTILITY(U,$J,358.3,4208,1,4,0)
 ;;=4^V82.9
 ;;^UTILITY(U,$J,358.3,4208,2)
 ;;=^295700
 ;;^UTILITY(U,$J,358.3,4209,0)
 ;;=V76.52^^17^196^68
 ;;^UTILITY(U,$J,358.3,4209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4209,1,3,0)
 ;;=3^SCRN MAL NEOP COLON
 ;;^UTILITY(U,$J,358.3,4209,1,4,0)
 ;;=4^V76.52
 ;;^UTILITY(U,$J,358.3,4209,2)
 ;;=^322090
 ;;^UTILITY(U,$J,358.3,4210,0)
 ;;=99456^^18^197^2
 ;;^UTILITY(U,$J,358.3,4210,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4210,1,1,0)
 ;;=1^C&P F-T-F Visit
 ;;^UTILITY(U,$J,358.3,4210,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,4211,0)
 ;;=99456^^18^197^4
 ;;^UTILITY(U,$J,358.3,4211,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4211,1,1,0)
 ;;=1^C&P Telehealth Visit
 ;;^UTILITY(U,$J,358.3,4211,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,4212,0)
 ;;=99241^^18^197^5
 ;;^UTILITY(U,$J,358.3,4212,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4212,1,1,0)
 ;;=1^C&P ACE Chart Review
 ;;^UTILITY(U,$J,358.3,4212,1,2,0)
 ;;=2^99241
 ;;^UTILITY(U,$J,358.3,4213,0)
 ;;=99456^^18^197^6
 ;;^UTILITY(U,$J,358.3,4213,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4213,1,1,0)
 ;;=1^IDES F-T-F Visit
 ;;^UTILITY(U,$J,358.3,4213,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,4214,0)
 ;;=99456^^18^197^7
 ;;^UTILITY(U,$J,358.3,4214,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4214,1,1,0)
 ;;=1^IDES Telehealth Visit
 ;;
 ;;$END ROU IBDEI09V
